CCRC: Phase I Study of the Combination of Temsirolimus (CCI-779) and Pazopanib (GW786034) in Patients With Advanced Solid Tumours.
Phase of Trial: Phase I
Latest Information Update: 27 Mar 2012
At a glance
- Drugs Pazopanib; Temsirolimus
- Indications Solid tumours
- Focus Adverse reactions
- 27 Mar 2012 GlaxoSmithKline and Pfizer added as trial sponsor and lead trial centres as reported by ClinicalTrials.gov.
- 27 Mar 2012 Actual patients number is 8 as reported by ClinicalTrials.gov.
- 27 Mar 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.